Product/Composition:- | Pioglitazone Oral Tablets |
---|---|
Strength:- | 15 mg, 30 mg, 45 mg |
Form:- | Oral Tablets |
Reference Brands:- | Actos (USA, EU), Glustin (EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Pioglitazone enhances insulin sensitivity by activating PPAR-γ receptors in adipose tissue, muscle, and liver, improving glucose uptake and reducing hepatic glucose production. It lowers HbA1c levels effectively and can be used with metformin or insulin. Benefits include better glycemic control and preserved β-cell function in type 2 diabetes management.
Pioglitazone tablets are FDA-approved in the USA and authorized by the EMA in the EU for the treatment of type 2 diabetes mellitus, either as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas. Marketed under brands such as Actos, Glustin, and their generics, pioglitazone is classified as a thiazolidinedione. It improves glycemic control by enhancing insulin sensitivity in muscle and adipose tissues. Regulatory agencies emphasize cardiovascular risk evaluation and monitor for adverse effects like weight gain and edema. Pharmatradz.com offers regulatory-compliant sourcing and B2B access to pioglitazone from audited manufacturers globally.